首页> 美国卫生研究院文献>The British Journal of Ophthalmology >Analgesic effect of topical sodium diclofenac 0.1 drops during retinal laser photocoagulation
【2h】

Analgesic effect of topical sodium diclofenac 0.1 drops during retinal laser photocoagulation

机译:视网膜激光光凝过程中局部滴加双氯芬酸钠0.1%的镇痛作用

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

AIMS—To evaluate the analgesic effect of topical sodium diclofenac 0.1% during retinal laser photocoagulation.
METHODS—87 patients, 45 with proliferative diabetic retinopathy treated with two sessions of panretinal photocoagulation (group A), and 42 patients with non-proliferative diabetic retinopathy who underwent grid treatment of the posterior pole (19 bilaterally) (group B). Sodium diclofenac 0.1% or sodium chloride 0.9% drops were topically applied 30-135 minutes before laser treatment in a masked fashion. Patients who had two sessions were given the alternate drug in the second one. Pain level was evaluated immediately after laser treatment with the visual analogue scale (VAS). The results were statistically analysed.
RESULTS—Patients in group A reported pain in 85/90 sessions (94%). The average pain level was 44.2% with sodium diclofenac 0.1% drops and 53.1% with sodium chloride 0.9% drops (p = 0.011 by paired t test). Patients in group B reported pain in only 16/60 sessions (26.7%), and the pain level ranged from 10% to 60% regardless of the kind of drops used. There was no correlation in either group between level of pain and time interval from application of the drops to laser treatment (30-135 minutes) or average energy level used (100-500 mW).
CONCLUSION—Sodium diclofenac 0.1% is useful for pain reduction and should be applied before panretinal photocoagulation.

机译:目的:评估0.1%双氯芬酸钠在视网膜激光光凝治疗中的镇痛效果。
方法:87例,45例糖尿病性增生性视网膜病变经过两次全视网膜光凝治疗(A组)和42例非视网膜病变增生型糖尿病性视网膜病变,其后极(双侧19个)接受网格治疗(B组)。在以掩蔽方式进行激光处理之前,在30-135分钟内局部滴加0.1%的双氯芬酸钠或0.9%的氯化钠。有两次疗程的患者在第二次接受替代药物治疗。激光治疗后立即用视觉模拟量表(VAS)评估疼痛水平。结果经过统计学分析。
结果-A组患者报告有85/90次疗程疼痛(94%)。滴加双氯芬酸钠0.1%的平均疼痛水平为44.2%,滴加氯化钠0.9%的平均疼痛水平为53.1%(通过配对t检验,p = 0.011)。 B组患者仅在16/60疗程中报告疼痛(26.7%),并且无论使用哪种滴剂,疼痛水平在10%至60%之间。两组之间的疼痛程度和从滴药到激光治疗的时间间隔(30-135分钟)或使用的平均能量水平(100-500 mW)之间均无相关性。
结论—双氯芬酸钠0.1%有助于减轻疼痛,应在视网膜光凝之前应用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号